Has Nuvation Bio's 234% Surge in 2025 Already Reflected Its Growth Potential? [Yahoo! Finance]
Nuvation Bio (NUVB): Reassessing Valuation After a 78% Monthly Surge in the Share Price [Yahoo! Finance]
Nuvation Bio (NYSE:NUVB) had its price target raised by analysts at HC Wainwright from $10.00 to $18.00. They now have a "buy" rating on the stock.
Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List
Nuvation Bio (NUVB) Bounces Back 12% on Impressive Clinical Trial Result [Yahoo! Finance]